US 11,053,190 B2
Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
Ki Duk Park, Seoul (KR); ChangJoon Justin Lee, Seoul (KR); Dong Jin Kim, Seoul (KR); Ae Nim Pae, Seoul (KR); Hyun Ah Choo, Seoul (KR); Sun Joon Min, Seoul (KR); Yong Koo Kang, Seoul (KR); Yun Kyung Kim, Seoul (KR); Hyo Jung Song, Seoul (KR); Ji Won Choi, Seoul (KR); Min Ho Nam, Seoul (KR); Jun Young Heo, Seoul (KR); Seul Ki Yeon, Seoul (KR); Bo Ko Jang, Seoul (KR); Eun Ji Ju, Seoul (KR); Seon Mi Jo, Seoul (KR); and Jong-Hyun Park, Seoul (KR)
Assigned to NeuroBiogen Co., Ltd., Seongnam-si (KR)
Filed by NEUROBIOGEN CO., LTD., Seongnam-si (KR)
Filed on Apr. 24, 2020, as Appl. No. 16/858,433.
Application 16/858,433 is a division of application No. 15/516,395, granted, now 10,676,425, previously published as PCT/KR2015/010104, filed on Sep. 24, 2015.
Claims priority of application No. 10-2014-0132983 (KR), filed on Oct. 2, 2014; and application No. 10-2015-0132281 (KR), filed on Sep. 18, 2015.
Prior Publication US 2020/0308104 A1, Oct. 1, 2020
Int. Cl. C07C 237/06 (2006.01); C07C 231/12 (2006.01); C07C 237/04 (2006.01); C07C 237/20 (2006.01); A61K 31/167 (2006.01); C07C 309/04 (2006.01); A61K 31/16 (2006.01)
CPC C07C 237/06 (2013.01) [A61K 31/16 (2013.01); A61K 31/167 (2013.01); C07C 231/12 (2013.01); C07C 237/04 (2013.01); C07C 237/20 (2013.01); C07C 309/04 (2013.01)] 14 Claims
1. An α-aminoamide derivative represented by [Chemical Formula 1] or a pharmaceutically acceptable salt thereof:

OG Complex Work Unit Chemistry
R is hydrogen or C1-7 alkyl; and
X is selected from the group consisting of a halogen, alkyl, halogenated alkyl, alkoxy and halogenated alkoxy.